Formulation and Drug Delivery

Fabrication Modulation of Zein-based Fibers for Oral Delivery of Hydrochlorothiazide

August 03, 2020

This study suggests that using a simple centrifugal method can produce a natural polymer-blend molecule that can successfully be used as an oral delivery mechanism for poorly soluble drugs.

A Great Manipulation: The Value of Engineering Particle Properties

August 03, 2020

Particle engineering is a useful tool to manipulate API particles into a form that is manufacturable and deliverable to the patient.

Key Ingredients Needed to Drive the Success of Continuous Manufacturing

August 03, 2020

Understanding and overcoming excipient variation are crucial for successful continuous processes.

Commercialization Poses Challenges for Cell and Gene Therapies

August 02, 2020

The early success seen on the market for approved cell and gene therapies poses both technical and manufacturing challenges for pipeline candidates on the road to commercialization.

All Hands on Deck for Fill/Finish of Vaccines and Therapeutics

August 01, 2020

Outsourcing partners provide capacity and tech transfer expertise in the pharmaceutical industry response to the COVID-19 pandemic.

Pharmapack Organizers Announce 2021 Event to Move from January to May

July 30, 2020

Pharmapack Europe 2021 has been rescheduled after a careful review by the event organizers with key stakeholders.

Intravacc and Celonic Partner for COVID-19 Vaccine Development

July 29, 2020

The companies will combine Intravacc’s OMV delivery platform with S-proteins with Celonic’s CHOvolution mammalian cell expression system to produce B and T-cell responses against SARS-CoV-2.

Stakeholders Seek Increased User Fee Support for Biologics

July 24, 2020

Patient advocates, research experts, and industry are calling for more user fee revenues to support CBER programs to advance innovative therapies.

UK Government Provides Cash Boost for COVID-19 Vaccine Manufacture

July 23, 2020

The UK government is committing a further £100 million (US $127 million) to ensure that there is capability to manufacture a successful COVID-19 vaccine at scale in the UK.

EMA Sets Up Infrastructure to Support Real-World Monitoring of COVID-19 Vaccines

July 23, 2020

The European Medicines Agency has set up an infrastructure to support real-world monitoring of the efficacy and safety of COVID-19 vaccines and treatments.